Overview
This study focuses on psychosocial barriers at the patient level with the goal of promoting high quality decision making around clinical trials participation. The proposed study adapts the PRE-ACT model to racial and ethnic minority patients who were underrepresented in the original PRE-ACT study and will be combined with a patient navigator model.
Description
The primary objective of the proposed research is to employ a non-directive method to improve preparedness for consideration of clinical trials among racial minority patients by providing tailored information to address knowledge and attitudes towards clinical trials. This model has been previously studied in a primarily white, well-educated population. It is unknown how well this model adapts to meet the needs of diverse patient populations.
Eligibility
Inclusion Criteria:
- Participants must have a diagnosis of either advanced (metastatic) cancer or early stage disease for which they are undergoing oncological work-up, treatment or surveillance
- Participants must be at least 18 years of age
- Participants have a non-white race or Hispanic ethnicity recorded in their patient demographics in the electronic medical record
- Participant must have a life expectancy greater than three months based on the primary oncology team's clinical assessment.
- Participants must be able to read and verbally communicate in English.
- Participants must provide written informed consent.
Exclusion Criteria:
-